Research, Select, & Monitor Monday, April 23, 2018 7:43:10 AM ET  
Trade Ideas The Market Industries Stocks Portfolio

Ticker Lookup
Melinta Therapeutics, Inc.$7.45   

  Quote | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

Melinta Therapeutics, Inc. has an overall rank of 6693 out of 6819 stocks based on 4 positive rankings and 10 negative rankings.

Positive Rankings
Estimated Revenue Growth
Melinta Therapeutics rank is 85
Low/Rising MACD
The MACD remains negative, but is rising... suggesting a possible near-term correction. Of companies with a negative, but rising MACD, Melinta Therapeutics is ranked 122.
10 Day Gain
Melinta Therapeutics rank is 800
Melinta Therapeutics rank is 2219
Negative Rankings
High vPut/Call
Melinta Therapeutics has a high Put/Call ratio of 17.33 on active options expiring within the next 90 days. A high put-to-call ratio indicates there are more bearish investors than bullish investors for the stock. Among companies with a high Put/Call Ratio, Melinta Therapeutics is ranked 47.
90 Day Loss
Melinta Therapeutics rank is 144
Negative Net Margin
Melinta Therapeutics rank is 345
Negative ROE
Melinta Therapeutics rank is 369
Down Ratings Revision
During the past month, the average analyst's rating or recommendation has decreased. Among companies that have been downgraded within the past month, Melinta Therapeutics is ranked 373.
Negative Cash Growth
Melinta Therapeutics rank is 531
Negative ROA
Melinta Therapeutics rank is 570
Melinta Therapeutics rank is 708
Down EPS Surprise
Melinta Therapeutics missed the consensus earnings estimate when it last reported quarterly earnings.
Melinta Therapeutics rank is 1510

Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results, the logo, and News Selects are trademarks of
Copyright © 1998 - 2018 All rights reserved.